Shingles vaccine linked to lower dementia risk in new study
A Sydney hospital will start a new study. It will test if the shingles vaccine can help prevent or delay dementia.
Why it matters
If proven, the vaccine could offer a simple way to reduce dementia risk. Dementia is Australia's leading cause of death.
In Australia. Federal Health Minister Mark Butler said he would consider lowering the free vaccine age from 65 if stronger evidence emerges.
Key facts
- January 2027
- Study start date
- St Vincent's Hospital, Sydney
- Study location
- 20% over 7 years
- Welsh study reduction
- 65 years
- Current free vaccination age
- Australian researchers are starting a study in January 2027.
- The researchers want to see if the shingles vaccine links to lower dementia risk.
- St Vincent's Hospital in Sydney will take blood samples from people over 60.
- The team will collect samples before vaccination and after.
- They will track changes in markers linked to brain inflammation and Alzheimer's disease.
- Research overseas and in Australia shows something important.
- People who get the shingles vaccine may be less likely to develop dementia.
- A Welsh study found a 20 per cent reduction over seven years.
- One idea is the virus itself may harm the brain.
- This can happen even without causing shingles.
- Another idea is that vaccination strengthens immune health as people age.


